Trials / Completed
CompletedNCT04336761
Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 901 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | nasopharyngeal swab | Data collection and nasopharyngeal swab |
Timeline
- Start date
- 2020-04-15
- Primary completion
- 2021-01-01
- Completion
- 2021-01-01
- First posted
- 2020-04-07
- Last updated
- 2021-03-11
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04336761. Inclusion in this directory is not an endorsement.